📄 Cross-examination of Dr. Fredric Rieders (part 1) — Monday, July 24, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUL\24\CROSS-EXAMINATION-OF-DR-FREDRI.DOC
TRIAL
▲ Day 120 of 167

Cross-examination of Dr. Fredric Rieders (part 1)

Witness: Dr. Fredric Rieders
Examiner: Marcia Clark
Called by: Defense • Date: Monday, July 24, 1995 • Utterances: 385
Marcia Clark cross-examines defense toxicology expert Dr. Fredric Rieders, attacking the foundation of his EDTA testimony by exploiting a possible typo in the EPA report he used to establish normal blood EDTA levels—forcing him to call the document an 'absurdity' while having just relied upon it. Clark also elicits a damaging concession that FBI Agent Martz's own unpreserved blood produced EDTA characteristics 'surprisingly' similar to the gate and sock stains, directly undermining the defense's planted-blood theory. Judge Ito issued a stern sidebar warning to Clark for editorial commentary during questioning.
1 MS. CLARK:

Thank you, your Honor.

CROSS-EXAMINATION BY MS. CLARK

2 MS. CLARK:

Dr. Rieders, good afternoon.

3 DR. RIEDERS:

Good afternoon.

4 MS. CLARK:

Now, you've just testified, sir, that according to you, your reading of an EPA report, that normally you will find no more than two or four parts per billion EDTA in a normal person's blood. Is that what you just said, sir?

5 DR. RIEDERS:

Yes. That normal is no more than four parts per billion. Right.

6 MS. CLARK:

Okay. No more than. In other words, you're saying that the maximum amount of EDTA that you will find in a normal person's blood is no more than four parts per billion, correct?

7 DR. RIEDERS:

That's what the EPA says and I accept that. I have nothing better.

8 MS. CLARK:

And that's based on the report that you had; is that correct, sir?

9 DR. RIEDERS:

It's an EPA publication, the ONTADS, which is one of their publications.

10 MS. CLARK:

Now, if what that--strike that. In the evidence stain, sir, you said you found EDTA in the levels of parts per million, correct?

11 DR. RIEDERS:

I didn't find it. Mr. Martz did and I agreed that they are in the parts per million based on his analysis.

12 MS. CLARK:

So the amount of EDTA found in the evidence stains on the gate and the sock were in parts per million; is that right?

13 DR. RIEDERS:

Yes. Because you cannot detect anything that is less than parts per million in any of the samples that he prepared or tested. His detection limit is in the parts per million.

14 MS. CLARK:

The answer is yes. The amount that was found in the gate and the sock were in parts per million, correct?

15 DR. RIEDERS:

Yes.

16 MS. CLARK:

And the amount that should be found, the maximum amount that could be found in a person, a normal healthy person's blood is in parts per billion, correct?

17 DR. RIEDERS:

Yes, according to the best available information.

18 MS. CLARK:

And if that information is incorrect and the actual information is in parts per million, then the amount found in the gate and the sock are a normal person's maximum allowable amount; wouldn't that be true, sir?

19 DR. RIEDERS:

If the best information is it's parts per billion, then yes.

20 MS. CLARK:

I have a report to show you, sir.

21 MS. CLARK:

We received a report I'm showing to counsel now. I ask it be marked as People's next in order.

22 THE COURT:

I'm sorry? 534.

23 MS. CLARK:

May I see a copy of the EPA report you referred to, sir? Do you have it with you?

24 DR. RIEDERS:

No. I furnished a copy to you and to Mr. Martz. I mean, actually I furnished copies--let me see what I have.

25 THE COURT:

Miss Clark, the evidence number, will be 537 on this.

26 MS. CLARK:

Thank you, your Honor.

27 THE COURT:

What's the source of this report, Miss Clark?

28 MS. CLARK:

The source of that report is--

29 (Peo's 537 for id = report)
30 MS. CLARK:

Excuse me.

31 DR. RIEDERS:

Yep, I have a copy.

32 MS. CLARK:

You have it, sir?

33 DR. RIEDERS:

Yes.

34 MR. BLASIER:

Miss Clark, may I have a copy?

35 MS. CLARK:

The source of this is EPA, your Honor.

36 MS. CLARK:

I'm going to show you what's now been marked as People's 537.

37 MS. CLARK:

And I'm going to ask if we can have it copied for counsel so they can keep it with them.

38 THE COURT:

How many pages is that?

39 MS. CLARK:

One page.

40 MS. CLARK:

Do you see the relevant passage at the bottom, sir?

41 DR. RIEDERS:

Yes. I see the problem.

42 MS. CLARK:

Yes, you see the problem, sir. Is that what you said?

43 DR. RIEDERS:

No. I see the paragraph.

44 MS. CLARK:

Oh, I see. And what does it say here?

45 MR. BLASIER:

Objection to the comments by counsel.

46 THE COURT:

Sustained. Jury is to disregard. Miss Clark.

47 DR. RIEDERS:

I said clearly "Paragraph."

48 MS. CLARK:

I'm sorry?

49 DR. RIEDERS:

I said clearly "Paragraph," not "Problem."

50 MS. CLARK:

"Paragraph." Tell the jury what this means in terms of amount, sir? "EDTA should not exceed two milligrams per milliliter of blood." What does that translate to in terms of either parts per million or parts per billion?

51 DR. RIEDERS:

What that is, it should not be less than 2,000 parts per million. That's the same amount that you find in EDTA in blood. At two parts at million--at 2,000 parts per million EDTA in blood, the blood won't clot. People will bleed to death all over the place. It's absurd.

52 MS. CLARK:

It's absurd. This is the basis for the EPA report that you referred to, sir, this absurd thing here?

53 THE COURT:

Excuse me, counsel. Is that a question?

54 DR. RIEDERS:

I beg your pardon.

55 MR. BLASIER:

Objection.

56 THE COURT:

Wait, wait, wait, wait, wait. Is that a question, Miss Clark?

57 MS. CLARK:

It was foundational to a question. I wanted to show him the report.

58 THE COURT:

Be careful, Miss Clark.

59 MS. CLARK:

Let me show you another report. Now, the report that you just pulled out from your briefcase, sir, I'm going to cite you to a passage where it says, "Insight to amelioration AML, dredge undissolved solid." That's in your report, correct?

60 DR. RIEDERS:

That's part of their report. That's part of the copy that I gave you.

61 MS. CLARK:

This is the EPA report that you used to base your opinion on that the normal amount of EDTA that you'll find in blood or the maximum allowable amount in a normal healthy person would be in the parts per billion, correct?

62 DR. RIEDERS:

This and the paper by Trujillo and foreman is--foreman is the other author.

63 MS. CLARK:

Now, with respect to this report, sir, on which you just said you based your opinion from the EPA, you read that to allow for the maximum allowable amount in a normal person to be two parts per billion?

64 DR. RIEDERS:

Right.

65 MS. CLARK:

Right. Now, is it possible, sir, that you have a typo here that caused you to conclude there were two parts per billion as the maximum allowable when in fact, it is 1,000 times less, two parts per million as the maximum allowable amount in a normal healthy person?

66 DR. RIEDERS:

It's possible that this is a typo, but this is--a 2,000 parts per million is absurd as I told you. The people would be bleeding to death at that level.

KEY QUOTE
67 MS. CLARK:

In other words, if this is the correct EPA report, you disagree with it?

68 DR. RIEDERS:

Well, obviously. I mean, it's--obviously it's a typo in there because I can't imagine that the EPA would say that it's all right to run around with blood that won't clot.

69 MS. CLARK:

Sir, you earlier just premised your person on the maximum allowable amount for a normal person on the EPA report, correct?

70 DR. RIEDERS:

That's correct.

71 MS. CLARK:

And in your report, it says two mg/ml?

72 DR. RIEDERS:

Yes.

73 MS. CLARK:

And you interpret that to mean two nanograms per milliliter?

74 DR. RIEDERS:

Yes. That's the only one possible.

75 MS. CLARK:

That's the only one possible from an ng as oppose to an mg, correct?

76 DR. RIEDERS:

That's correct.

77 MS. CLARK:

And so you determined that what the EPA was saying was the maximum allowable amount was two parts per billion, correct?

78 DR. RIEDERS:

That they were saying what is consistent with their radioactive study, and that's what they say, yes. Sure. Makes sense.

79 MS. CLARK:

But the radioactive study, sir, was not able to pick up EDTA in the blood, was it?

80 DR. RIEDERS:

That's correct.

81 MS. CLARK:

It gave no lower trace amounts that it was able to detect or measure in blood, did it?

82 DR. RIEDERS:

I'm sorry?

83 MS. CLARK:

That report back in the 50's of radioactive EDTA did not state any specific amount for anything detected in blood resembling EDTA; isn't that correct?

84 DR. RIEDERS:

That's not correct.

85 MR. BLASIER:

Your Honor, I object. I thought we weren't going into this. I mean I'm happy to.

86 THE COURT:

Sustained.

87 MS. CLARK:

I can't--

88 THE COURT:

Sustained.

89 MS. CLARK:

What was the objection?

90 THE COURT:

Court's previous ruling on this regard, that report. Proceed.

91 MS. CLARK:

The witness continues to refer to it. Then I'd ask the witness' references to be stricken.

92 THE COURT:

Proceed.

93 MS. CLARK:

You just testified that you based your opinion on this EPA report. Isn't that what you just did on direct examination, sir?

94 DR. RIEDERS:

I didn't say--I didn't say I didn't base it on anything else. Yes, that's what I said.

95 MS. CLARK:

Thank you, sir. And you interpreted that report to say that the normal amount you would find, a maximum allowable amount in a normal healthy person would be two parts per billion, correct?

96 DR. RIEDERS:

Yes.

97 MS. CLARK:

And that the amount that you found in the gate and the sock stains were in the parts per million, correct?

98 DR. RIEDERS:

I didn't find it. The amounts that the FBI found were in the parts per million, yes.

99 MS. CLARK:

And based on those differences on the parts per billion that you would find in the normal healthy person, which is far less wouldn't you agree, than in parts per million, correct?

100 DR. RIEDERS:

Yes.

101 MS. CLARK:

Based on that, sir, you concluded that the amount of EDTA found in the gate and the sock stains could not have come from food, correct?

102 DR. RIEDERS:

It is reasonably certain that they did not come from food. Could--

103 MS. CLARK:

And that is based on the maximum allowable amount that you determined--

104 THE COURT:

Excuse me, counsel. Counsel, you need to allow the doctor to finish his answer.

105 MS. CLARK:

I'm sorry.

106 MS. CLARK:

Doctor, did you finish your answer?

107 THE COURT:

The question was regarding whether or not the EDTA in the gate and sock stains could have come from food.

108 DR. RIEDERS:

Not from ingested foods being transferred into the blood of a person from whom that blood came. That in my opinion is so unlikely that I would not consider it.

109 MS. CLARK:

Now, doctor, that is based on your interpretation--that is based on the report from the EPA that talks about the maximum allowable amount of EDTA in a normal person, correct?

110 DR. RIEDERS:

And on the foreman and Trujillo paper.

111 MS. CLARK:

And I'll object. The latter part is nonresponsive under 352.

112 THE COURT:

Overruled. Proceed.

113 MS. CLARK:

And you also determined--then, doctor, if your interpretation or your reading of that report saying two parts per billion in the normal healthy person is based on a typo and in fact, they meant to say two parts per million, what they are stating there in the two parts per million is consistent with the amount of EDTA that was found by Agent Martz in the gate and the sock stains; isn't that correct?

114 DR. RIEDERS:

I beg your pardon. It's 2,000 parts per million. Two milligrams per mil is 2,000 parts per million, the same that was--that's--or more so than you find in an EDTA tube. That is blood that won't coagulate.

115 MS. CLARK:

Did you see the report on which it's based, sir? In other words, you're insisting that this EPA report is wrong. Is that your testimony?

116 DR. RIEDERS:

I don't say that the report is wrong if that's what they put in. I think it's either a typo or a complete absurdity.

117 MS. CLARK:

Now, I'm showing you the report faxed to us by the EPA on which the report you have is based, and that's the one just shown to counsel, People's 357. And it says the same thing, does it not, two milligrams per milliliter? Isn't that correct?

118 MR. BLASIER:

Your Honor, I still don't have a copy of this. Could we have a copy of this, please?

119 DR. RIEDERS:

It is a--it is a--it describes the content of the paper. It is not a report. It says that: "Observation on the effect of the concentration of EDTA on the packed cell volume of various domestic animals confirm that in man, the concentration of EDTA should not exceed two milligrams per milliliter of blood." The citation is the British veterinary journal. So it--I mean, you know, I don't quite understand it if this is on animals or why this applies to man, and, secondly, if it is supposed to--this is not a report. This is an abstract of a paper--it's an absurdity.

120 MS. CLARK:

But it does use the same amount; does it not, doctor? You see that you have 2 mg/ml, they have 2 mg/ml, and we have a report that conforms to the report on which it's based. I just had you read it, have I not, where it says--

121 DR. RIEDERS:

No, you haven't. You have not made me read it.

122 MS. CLARK:

You haven't seen this, doctor?

123 DR. RIEDERS:

No, I haven't seen this. No.

124 THE COURT:

All right. Miss Clark, "This" that Dr. Rieders has is what?

125 MS. CLARK:

People's 358.

126 THE COURT:

You mean 538.

127 MS. CLARK:

538?

128 THE COURT:

538. You have your numbers transposed.

129 MS. CLARK:

Thank you, your Honor. Let me write this down.

130 (Peo's 538 for id = document)
131 MS. CLARK:

Don't you recall us just reading this together, Dr. Rieders?

132 DR. RIEDERS:

No. You read it to me. I didn't have a chance to look at it

133 (Brief pause.)
134 DR. RIEDERS:

This--

135 THE COURT:

All right. Miss Clark.

136 MS. CLARK:

Have you read it, sir?

137 DR. RIEDERS:

Yeah, I've read it.

138 MS. CLARK:

All right. So in my copy, it says 2 mg/ml, doesn't it, for the same--

139 DR. RIEDERS:

Your copy of something else. This is not the same. Will you please note that these are different references from another base?

140 MS. CLARK:

Yes. But the paragraph it applies to is word for word the same as yours; isn't that correct?

141 DR. RIEDERS:

Except for that, that's correct.

142 MS. CLARK:

So it's referring to the same thing, isn't it, doctor?

143 DR. RIEDERS:

I expect so. But I don't know that.

144 MS. CLARK:

Well, you just read it.

145 DR. RIEDERS:

Well, I don't know that it refers to the same thing, but--

146 MS. CLARK:

Let's read it together, doctor. Tell me where the words are different.

147 DR. RIEDERS:

It doesn't except for that one little thing. This is absurd, what's in here.

148 MS. CLARK:

All right. All right. Here it says two 2 mg/ml.

149 DR. RIEDERS:

Yeah.

150 MS. CLARK:

The paper on which--that was sent to us from the EPA, People's 536, says the same? 2--

151 DR. RIEDERS:

Excuse me. The paper does not say that. They are abstracts it says.

152 MS. CLARK:

So exactly the same; is that correct, doctor?

153 DR. RIEDERS:

Yeah.

154 MS. CLARK:

All right. Now, these are based on animal studies; are they not?

155 DR. RIEDERS:

That's what the paragraph says. I don't know that paper. I'd have to read it to give you an opinion on it.

156 MS. CLARK:

Yesterday, doctor, you were willing to base your opinion on the parts per billion that you thought was actually written there earlier on direct testimony, correct?

157 DR. RIEDERS:

Because--yes, because all it did was corroborate what the radioactivity studies showed, that they couldn't find any in their detection limit, it being one part per billion.

158 MS. CLARK:

And, doctor, in these radioactivity studies, there is no amount shown; isn't that correct?

159 DR. RIEDERS:

But it's clearly there. It's not written out, but it's clearly there. They used radioactivity--active labeled EDTA that they gave people by mouth. They could not detect it. They show you how many DPM's they can count at the various levels, and what is not detected is, it's no more than one to two parts per billion.

160 MS. CLARK:

Doctor--

161 DR. RIEDERS:

If it's more than that, it's detected.

162 MS. CLARK:

Doctor, what kind of equipment or facilities did they have for testing back then? Did they have the LC--did they have the liquid chromatograph tandem mass spectrometer back then?

163 DR. RIEDERS:

This has nothing to do with it. This is radioactive material fed to people, which is much more sensitive than any instruments that we have nowadays.

164 MS. CLARK:

Well, let me--

165 DR. RIEDERS:

You can't just feed it to people anymore.

166 MS. CLARK:

Doctor, let me ask you this. Have you done any studies to take blood from normal people that is not preserved and tested for trace levels of EDTA? Have you done that?

167 DR. RIEDERS:

I have done no such experiments. No.

168 MS. CLARK:

Now, you wrote your report on July 17th of this year?

169 DR. RIEDERS:

I guess so. I'll have to look at the date. It's the date that's on the report, whatever that is.

170 MS. CLARK:

July 17th. And you got Agent Martz' reports back in the end of February, beginning of March, correct?

171 DR. RIEDERS:

Which report?

172 MS. CLARK:

The graphs and the notes by Agent Martz?

173 DR. RIEDERS:

I don't remember the exact date, but probably in March sometime I think. I'm not even sure I got them in March. But never mind. I got them quite a while ago.

174 MS. CLARK:

And you didn't write a report documenting your findings until July 17th, correct?

175 DR. RIEDERS:

That's when I was asked to write one, yes.

176 MS. CLARK:

Otherwise, you wouldn't have written one at all?

177 DR. RIEDERS:

I only write reports if I'm asked to write them. It's customary.

178 MS. CLARK:

It's customary for you to do as you are instructed by the Defense counsel that hire you, correct?

179 DR. RIEDERS:

Only instructed in terms of what he wants me to do and what he wants me to give them. That's his prerogative.

180 MS. CLARK:

Okay. And when you wrote that report on July 17th, you had not yet spoken to Agent Martz about his testing, correct?

181 DR. RIEDERS:

Right.

182 MS. CLARK:

You had just read what he had done; is that right?

183 DR. RIEDERS:

Most of it, not all. I received some after that.

184 MS. CLARK:

And after you wrote that report, you discovered that Agent Martz tested his own normal blood unpreserved for the presence of EDTA and found EDTA; did he not?

185 DR. RIEDERS:

His results that he forwarded to me showed an EDTA peak in the blood that he processed, yes.

186 MS. CLARK:

In fact, isn't it true, doctor, that his own unpreserved blood came up very similarly in results to the bloodstains found on the gate and the sock? Isn't that true, doctor?

187 DR. RIEDERS:

Surprisingly, yes.

188 MS. CLARK:

Yes.

189 DR. RIEDERS:

It did not came--excuse me.

190 MR. BLASIER:

Objection.

191 DR. RIEDERS:

The numbers came out the same.

192 THE COURT:

Hold on.

193 DR. RIEDERS:

Excuse me.

194 THE COURT:

Hold on. Wait.

195 DR. RIEDERS:

I'm sorry.

196 THE COURT:

Wait. Let me see counsel at sidebar with the court reporter, please.

197 (The following proceedings were held at the bench:)
198 THE COURT:

All right. We're over at the sidebar. Miss Clark, I cautioned you to be careful earlier. Your commentary on the testimony, I realize you're enjoying yourself, but I'm warning you right now, warning you in no uncertain terms, if I see any more of that commentary, there's going to be severe sanctions, and I underline the word "Severe." Proceed.

199 (The following proceedings were held in open court:)
200 THE COURT:

Thank you, counsel. Proceed. Miss Clark, 2:30.

201 MS. CLARK:

Thank you, your Honor.

202 MS. CLARK:

Now, doctor, as you've indicated, you are interpreting Agent Martz' work; is that correct?

203 DR. RIEDERS:

His results, yes. His results, yes.

204 MS. CLARK:

You did not do any testing yourself; isn't that correct?

205 DR. RIEDERS:

None whatever.

206 MS. CLARK:

As a matter of fact, your lab doesn't even have this equipment, does it?

207 DR. RIEDERS:

We don't have the equipment that Roger Martz has. That's correct. Not yet.

208 MS. CLARK:

Do you even have the liquid chromatograph tandem mass spectrometer?

209 DR. RIEDERS:

No.

210 MS. CLARK:

Let alone one that has the electrospray?

211 DR. RIEDERS:

Well, that's just one interface. No. We don't have any.

212 MS. CLARK:

As a matter of fact--

213 DR. RIEDERS:

The only one that we do have is the ability to collect fractions and analyze them separately by the mass spectrometer, something which I've done.

214 MS. CLARK:

You yourself have never operated the electrospray; isn't that correct?

215 DR. RIEDERS:

That's correct.

216 MS. CLARK:

Now, doctor, wouldn't you agree that the person that would be the most qualified to testify and interpret the results of the operation of a given machine is somebody who operates that machine on a daily basis?

217 DR. RIEDERS:

He should be the most qualified person to determine what the limits of ability of his machine are since he works with it every day. Yes.

218 MS. CLARK:

And in that regard, sir, you testified earlier that you thought retention time was a significant factor in determining whether or not these stains had the same qualities as those found in the reference blood samples with respect to the presence of EDTA; isn't that right?

219 DR. RIEDERS:

Yes.

220 MS. CLARK:

And if an expert in the operation of this machine such as Agent Martz told you that retention time was an inappropriate factor to use because it is not discriminating for the presence of EDTA, wouldn't you agree that retention time should not be relied upon to determine whether or not a substance is or is not EDTA?

221 DR. RIEDERS:

Well, if he told--if he were to tell me that, I would tell him that he's in error because retention time is a characteristic of a substance in a chromatography system provided there is some reasonable reproducibility of flow and other things, that's possible. It's independent of the detection system and all these other things and the variability may be greater in one than in another, but it is usable and it is used for that, yes. That's what I would tell him. He didn't tell me that it's not applicable. Retention time is always a characteristic of a substance unless you change conditions completely.

222 MS. CLARK:

Well, let me ask you this, doctor. When you do testing to determine whether or not you think something is present, chemically speaking, wouldn't it be important to use factors that are as unique and as rare as possible in determining whether or not a compound is or is not a given chemical? Wouldn't you agree?

223 DR. RIEDERS:

Only if you add the one other thing "And available." If you can do cer--within the framework of what you can do, are you doing all you can to get the most intimately characterizing property of the substance that differentiates it from others, yes.

224 MS. CLARK:

Yes?

225 DR. RIEDERS:

Yes.

226 MS. CLARK:

Doctor, let me ask you this. If you are attempting to find women that look like me, wouldn't it be far more efficient to say you want a woman of this height and this weight--and I'm not going to say what that is--and this kind of hair and these kind of eyes and that kind of mouth and those kind of arms as opposed to just saying I want a woman five foot six?

227 MR. BLASIER:

Objection.

228 MS. CLARK:

By Miss Clark: Wouldn't you agree?

229 THE COURT:

Sustained.

230 MS. CLARK:

Is it because of the weight thing, your Honor?

231 THE COURT:

It's too oblique for me.

232 MS. CLARK:

All right.

233 MS. CLARK:

What I'm getting at, doctor, is, if you use criteria that are very broad, then you will include a lot that does not belong in that category, correct, as a general proposition?

234 MR. BLASIER:

Objection. Objection. Vague.

235 THE COURT:

Overruled.

236 DR. RIEDERS:

I will use all available criteria, broad, narrow, microscopic and assign to each one a probative value for what a scientist does, and that is applying what is called the null hypothesis.

237 MS. CLARK:

All right, doctor. Let me ask you this. If you assign probative value, if an expert in the operation of this machine who uses it every day like Agent Martz were to tell you that retention time has very little probative value because all chemicals seem to pass through at almost the same time or within a minute, would you agree, doctor, that that is not a factor that should be given great probative value in your determination as to whether or not a compound is or is not EDTA?

238 DR. RIEDERS:

Well, if you were to tell me that, I will tell you that you are grossly mistaken. And if you earnestly believe that all compounds will pass through in a short time when you have a column, you don't know what you're talking about.

239 MS. CLARK:

But, doctor, you would agree, would you not, that someone who runs that machine every day would be a better expert, better able to determine what are the probative factors and are not than someone else who has never operated it? Wouldn't you agree, doctor?

240 MR. BLASIER:

Objection. Argumentative.

241 THE COURT:

Overruled.

242 DR. RIEDERS:

He should be, but if he says that, he isn't.

243 MS. CLARK:

Doctor, isn't it true that most compounds will pass through this particular, the electrospray in particular, in about one minute?

244 DR. RIEDERS:

It will pass through the electrospray in one minute, but the separation occurs in the chromatography column.

245 MS. CLARK:

That's right. And in the column, sir, how long does it take, if you know--do you even know how long it takes most compounds to pass through the column in the LC tandem ms?

246 DR. RIEDERS:

That will depend on what column and what flow you use. He doesn't say how much time it takes. He has everything down in terms of scan numbers. So I can't tell you. It's a few minutes between runs, and that rather surprised me, that so little separation time is allowed and--but that's all. I still can't--I can't tell you a thing about it. If he knows what he's doing, then he's using a column to separate substances. As far as I know, he knows what he's doing and that's what he's doing. So he separates them.

247 MS. CLARK:

Doctor, he conferred with you on at least one occasion, correct?

248 DR. RIEDERS:

We talked about this on at least one occasion, yes.

249 MS. CLARK:

Okay. And as a matter of fact, you've had his reports for--or his notes and the graphs for months, correct?

250 DR. RIEDERS:

That's correct.

251 MS. CLARK:

Was there anyone who prevented you from picking up a phone to ask him about these questions, sir?

252 DR. RIEDERS:

Yes.

253 MS. CLARK:

Who?

254 DR. RIEDERS:

It's not customary for me to do that. I asked the attorneys to get me additional information or to suggest that I call him up and talk to him on the phone. I got additional information, not all that I asked for, but I did not get their okay to call him. And although I realize I can do it, you know, I'm a free man, it's not a very proper thing if you--if you are going contrary to the wishes of the people that you talk to unless those wishes are an obvious crime or something.

255 MS. CLARK:

And the Defense attorneys told you when to write your report and who you may call and not call; is that correct?

256 DR. RIEDERS:

No.

257 MS. CLARK:

You wait for their permission; is that correct?

258 DR. RIEDERS:

Not their permission.

259 MR. BLASIER:

Objection. Argumentative.

260 THE COURT:

Overruled.

261 DR. RIEDERS:

I do not wait for their permission. I asked them whether they have wishes, not orders. And if their wishes are reasonable, I'll comply with them of course.

KEY QUOTE
262 MS. CLARK:

Doctor, you're a scientist; are you not?

263 DR. RIEDERS:

Yes.

264 MS. CLARK:

It's important for you to get as much data, as much information as you possibly can so your answers are all as correct and reliable as they can be; isn't that true?

265 DR. RIEDERS:

If I can obtain that information properly, yes.

266 MS. CLARK:

And would it have been improper for you to ask Agent Martz to furnish you with information on the validity or the probative value of retention time, for example, in this particular piece of equipment in which he is an expert in its use?

267 MR. BLASIER:

Objection. Argumentative, vague as to what's improper, what that means.

268 THE COURT:

Overruled.

269 DR. RIEDERS:

Either ask that question specifically or ask it in a more general way, which I did, to the attorneys, and that is that I would like to see the validation data for all the perimeters that apply to this analysis. Retention time is one of the most important perimeters, and the validation data that I received contained retention times which put it exactly into the range that they were. So it worked fine.

270 MS. CLARK:

Doctor, you operate the gas chromatograph, correct?

271 DR. RIEDERS:

Yes.

272 MS. CLARK:

And the gas chromatograph, retention time is a very important factor, isn't it?

273 DR. RIEDERS:

In every chromatography, retention time or RF or RT, whatever they are called--it's the same thing. They just attach different letters to them--is one of the characterizing properties of individual compounds or sometimes the groups of compounds depending how you are doing the analysis.

274 MS. CLARK:

And, doctor, in the use of the gas chromatograph, you will be able to detect items by how long they take to separate, correct, and some items take a great deal of more time than others?

275 DR. RIEDERS:

Not how long they take to separate, but how well separated they are in the run.

276 MS. CLARK:

By the time they get to the end of the column?

277 DR. RIEDERS:

Well, separated somewhere, whether they--by the time--they are measured by the time they get--at the end of the column, the time is recorded, and the time between one peak and the next peak has to be sufficient so that they are clearly two peaks.

278 MS. CLARK:

And what is the amount of time, maximum amount of time that it would take an item to go through your column, the gas chromatograph column?

279 DR. RIEDERS:

That is so variable. I have substances just go through the column, through one column in less than a minute. I have others which take 40 minutes in that or in other columns. It is as long as you want it to be. For instance, in the EPA studies, there are runs that are two hours long. So, you know, it's--it's what you're looking for and what you're doing. As long as you know what you're doing, you're all right.

280 MS. CLARK:

All right, doctor. In your experience then with the gas chromatograph that you routinely operate, you can have items that run through the column for as long as 40 minutes, correct, that have retention time as long as that?

281 DR. RIEDERS:

Yeah. I think in one of the types of analysis that we do--we do many different types--there is as much--it's a screen and it extends over something like 40 minutes.

282 MS. CLARK:

Now, doctor, if Agent Martz were to tell you that because of the way the electrospray works, he's required to use very volatile liquid to push the material through the column such as pneumonia, and as a result of that, just about all substances go through in one minute, what in your opinion would be the probative value of retention time?

283 DR. RIEDERS:

It would still be the retention time of a substance within 10 seconds, 20 seconds, 30 seconds, 40 seconds, 50 seconds, 60 seconds. The last one is six times as long as the first one. So whatever the time is--I'm sure he isn't pushing it through a column for the fun of it because if it's so close that you can't differentiate, why use a column at all.

284 MS. CLARK:

Nevertheless, doctor, if that were the case, then wouldn't you agree that retention time is not a very discriminating factor in the LC tandem and mass electrospray?

285 DR. RIEDERS:

It is a discriminating factor. I don't want to assign to it very little--it's a discriminating factor. It's a property. It takes a certain length of time for EDTA to go through. So that's one of its characteristic. If he knows of 50 other substances not related to EDTA that have the same retention time and if you'll tell me, then I say well, then it still is a characteristic, but it is shared with other substances.

286 MS. CLARK:

And so--

287 DR. RIEDERS:

Now, if these substances are indeed things that you find in blood, then it's important. If they are substances that you only find in the Gulf of Mexico, then they are irrelevant because your test has to be something that has a meaning in terms of the analysis that you do. If they are cyanide and other horrible poisons, then in this case, it's irrelevant because there's none there.

288 MS. CLARK:

All right. Now, doctor, then in that case--but in that case, if there were say 50 other compounds that pass through at the same retention time, the probative value would be less?

289 DR. RIEDERS:

Of course.

290 MS. CLARK:

Correct?

291 DR. RIEDERS:

If you can tell me that's less than if you only know of two others.

292 MS. CLARK:

Well, doesn't the retention time to some degree depend on the kind of liquid used to push the material through the column? Isn't that true?

293 DR. RIEDERS:

Among other things, of course.

294 MS. CLARK:

And if you routinely use the same liquid repeatedly--

295 DR. RIEDERS:

Uh-huh.

296 MS. CLARK:

--isn't it true, doctor, that you're going to wind up with a lot of compounds with the same retention or very similar retention time as opposed to using different liquids?

297 DR. RIEDERS:

I don't know that. You don't have to. You have a good separation or you don't. I don't know.

298 MS. CLARK:

And you don't know because you don't operate the electrospray, do you, sir?

299 DR. RIEDERS:

Well, whether you operate the electrospray or not has nothing to do with that, nothing whatever. If the whole retention on that column is one minute, then you're working with a separation within one minute. There are gas chromatograms which separate 200 compounds in one minute that you put in there. So I'm sure it's the same that you can obtain here although LC is less of a separator.

300 MS. CLARK:

But you would agree with me, would you not, doctor, that if the retention time in the electrospray is very similar for many different compounds, then the retention time is not a very probative factor? Yes or no?

301 DR. RIEDERS:

It's a probative factor. Very--I don't know what is very, how much.

302 MS. CLARK:

Well, didn't you just tell us, sir, that you determined how probative certain factors are?

303 DR. RIEDERS:

Yeah.

304 MS. CLARK:

All right. Then obviously, there is some variation between the importance of certain factors and others, correct?

305 DR. RIEDERS:

Sure, there is.

306 MS. CLARK:

All right. Now, with respect to Agent Martz' blood, you have testified, sir, that since you wrote your report, you determined, you found out that Agent Martz tested his own blood and came up with characteristics just like those in the gate and the sock stains which you determined were EDTA, correct?

307 DR. RIEDERS:

There are two many questions in there. Let's take one at time. Would you mind?

308 MS. CLARK:

Is that an objection, compound?

309 MR. BLASIER:

Objection. Compound.

310 THE COURT:

Yes, it is. Sustained.

311 MS. CLARK:

Well, let me just show you a chart, sir. Now, while Mr. Blasier is reviewing that, I want to show you a chart which he showed you earlier.

312 MS. CLARK:

Did you mark this one or just show it?

313 (Discussion held off the record between the Deputy District Attorney and Defense counsel.)
314 MS. CLARK:

I'm putting up Defense--which Mr. Blasier will tell me in a moment.

315 MR. BLASIER:

1257-C.

316 MS. CLARK:

1257-C, your Honor.

317 MR. BLASIER:

No. I'm sorry. D.

318 MS. CLARK:

D.

319 MS. CLARK:

All right. You were speaking earlier, sir, of the fact that EDTA is comprised of the parent ion 292 and one proton is added, correct?

320 DR. RIEDERS:

Yes.

321 MS. CLARK:

And by the way, I think you indicated to counsel that the process of electrospray does not alter the ions. Didn't you say that, sir?

322 DR. RIEDERS:

It doesn't change one chemical to another.

323 MR. BLASIER:

Objection. Misstates the testimony, whether they change them.

324 THE COURT:

Overruled. Overruled.

325 MS. CLARK:

Didn't you testify to that sir? Tell me.

326 DR. RIEDERS:

I testified that the electrospray does not change one chemical into another. That includes ions of one chemical into ions of another chemical.

327 MS. CLARK:

Okay. But the ions are changed in some respect; are they not?

328 DR. RIEDERS:

They can be. They not all are. The main thing about electrospray is that it is capable of driving otherwise neutral molecules, lodge neutral molecules readily into the mass spectrometer. That's its great advantage.

329 MS. CLARK:

Now, when you do the gas chromatograph in the work that you've done, you measure the straight weight, correct, the straight weight of the ion with no additions?

330 DR. RIEDERS:

No, no, no. Positive, I also use m plus one, which is the molecular weight plus one. That's what you get.

331 MS. CLARK:

And that's what you do here; do you not? You're adding one to the molecular weight?

332 DR. RIEDERS:

Yeah. You're adding a proton, a positively charged hydrogen atom.

333 MS. CLARK:

All right. Now, you've testified, sir, that the parent ion 293 is one characteristic of the EDTA, correct?

334 DR. RIEDERS:

Yes.

335 MS. CLARK:

And that there is a daughter ion, 160, correct?

336 DR. RIEDERS:

Yes.

337 MS. CLARK:

But that is not the full daughter spectrum that you see there; isn't that correct?

338 DR. RIEDERS:

Not here. The full daughter spectrum is all the daughters.

339 MS. CLARK:

And the other daughter, which is not shown on this chart, is 132?

340 DR. RIEDERS:

That's one other daughter.

341 MS. CLARK:

And that other daughter ion, 132, was not present on the gate and the sock stains; isn't that correct?

342 DR. RIEDERS:

Oh, no. That's not correct. Remember that Mr. Blasier showed me a chromatogram which included the--all three, the 293, the 160 and I think the 130 or whatever it was, and all three of them were there, although not in high concentrations. They were below the concentration at which the instrument prints out retention time, peak height and number. It is below what is called the reporting limit of the instrument the way it's set.

343 MS. CLARK:

So what you're saying is, although you can't see it, it's really there?

344 DR. RIEDERS:

No, no. I can see it and so can the instrument. It just didn't label it. There's a big difference between that.

345 MS. CLARK:

All right, sir. I want to go back to that chart.

346 DR. RIEDERS:

All right.

347 (Discussion held off the record between the Deputy District Attorney and Defense counsel.) (Brief pause.)
348 MS. CLARK:

All right. Before we get to that chart, sir--we're going to try to locate that--are you familiar with the term "Noise"?

349 DR. RIEDERS:

Yes.

350 MS. CLARK:

And are you familiar with the maxim that a scientist requires three times the signal to noise ratio before saying that something could even exist? Have you heard that?

351 DR. RIEDERS:

I've heard some people claim that. Others, five, others, two, others, 10. It depends on the circumstances. This is not from Olympus. The important thing in determining the presence or absence of something is, can you see it above the noise in one way or another.

352 MS. CLARK:

All right. And when you say "Can you see it above the noise," you mean that there may be kind of jagged lines like this, but in order to call a peak an identification of something or a detection of something, that one peak that stands out has to be three times higher than those other lower jagged peaks; isn't that correct?

353 DR. RIEDERS:

No. Actually what is used is not that it has to be so much higher than the noise, but that it has to be higher by more than a certain number of standard deviations of the mean of the noise. That is what is used.

354 MS. CLARK:

In which case, you would expect though to see on the graph one peak higher than the rest; isn't that correct?

355 DR. RIEDERS:

Either that or a pattern which is clearly different and more like something there than nothing there.

356 MS. CLARK:

All right. Now, you're looking at this graph again, sir.

357 MS. CLARK:

Did you mark it, counsel?

358 MR. BLASIER:

1259-C.

359 MS. CLARK:

1259-C. Now, you determined that on this chart is shown the other daughter 132 because at the same retention time--

360 MS. CLARK:

Move over.

361 MS. CLARK:

Will you direct the arrow, sir, to where it was before? Tell the arrow where to go. See the arrow? Look on your monitor. Yeah.

362 DR. RIEDERS:

How do I do that?

363 MS. CLARK:

Tell it to go right or left.

364 DR. RIEDERS:

Go to the left a little bit. Hold. That's one peak (Indicating). Go to the right a little bit. No. Less than that. Here's another part of that peak. Go to the right. Little more. Little more. That's it. Now, there's another one. Now, let's go to a valley. Go over. No. Go to a valley. That's it. Little bit to your left. Now, go another arrow--little bit to the right. Okay. That's good enough.

365 MS. CLARK:

And it's your contention that that proves what?

366 DR. RIEDERS:

That this--the retention time of the first of these arrows is in one of the places where the retention time of EDTA has appeared. You have to bear in mind that this is a scan over an extremely wide range so that there's very little energy available to scan any one ion. So it is much less sensitive than if you do the same thing and always scan for 160 or for 293, but it's still strong enough to show a pattern which matches that scene in the parent ion and daughter ion chromatogram, which is a focus chromatogram.

367 MS. CLARK:

All right. You would agree, would you not, sir, that the other random peaks there are not three times lower than the peaks that you've pointed out, correct?

368 DR. RIEDERS:

They certainly are not.

369 MS. CLARK:

All right. Now, look down at the--down at 293.

370 DR. RIEDERS:

All right.

371 MS. CLARK:

There is a very high peak in the very beginning, isn't there, sir?

372 DR. RIEDERS:

What?

373 MS. CLARK:

The 293 is the parent ion; isn't it?

374 DR. RIEDERS:

Yes.

375 MS. CLARK:

Isn't it? And you see a very high peak where we've just put the magenta arrow? In fact, that's the highest peak on that graph, isn't it?

376 DR. RIEDERS:

That's correct.

377 MS. CLARK:

But you didn't call that--you did not identify that as the parent ion even though that does have a high peak, maybe three times as high as some of the other peaks on that chart; isn't that correct?

378 DR. RIEDERS:

No, I did not because I have nothing to go on to call it a parent ion.

379 MS. CLARK:

Then in fact, what this graph shows, sir, in your opinion, as the 132 is based solely on the fact that you see something at the retention time?

380 DR. RIEDERS:

At the same--yes, at the same retention time where I see the 160 and the 292 and at the same retention time where in the more focused chromatogram that we looked at previously where you can see much better that 160 and that--that--it's in the same place and even the pattern is somewhat similar. So that's why I say that--you saw it before at 160. Now, if you're scanning the whole thing, even though it is so much weaker--I mean this is probably, I don't know, it could be as much as a hundred times less sensitive than the 160 ion--you still see it, and in the same place where the 160 is, you also see the footprints of the 132 ion.

381 MS. CLARK:

And so are you willing to say, sir, to a reasonable degree of scientific certainty that based on this graph here of the 132 daughter ion, that it is present on the sock? Is that your testimony, sir?

382 DR. RIEDERS:

That what is present on the sock?

383 MS. CLARK:

The 130--that you have the full daughter spectrum on the sock based on this reading of your graph of 132?

384 DR. RIEDERS:

This is the full daughter spectrum on the sock unless there are other smaller ones, you know, unless there are other little pieces around which I have not looked here. And that's--in general is the weakest--the least sensitive of the methods that he could use, but at the same time, it's more specific. You're trading off one for the other.

385 THE COURT:

All right. Miss Clark, we're going to take our recess at this point. All right. Ladies and gentlemen, please remember all my admonitions to you. We'll take about 15 minutes for a break. And, doctor, you can step down.

Temperature

tense

Key Quotes (4)

Dr. Fredric Rieders
Surprisingly, yes.
Rieders concedes that Martz's own unpreserved blood yielded EDTA results nearly identical to those in the gate and sock stains—the very stains Rieders claimed showed blood-preservative additive consistent only with reference tube blood.
Dr. Fredric Rieders
It's possible that this is a typo, but this is—a 2,000 parts per million is absurd as I told you. The people would be bleeding to death at that level.
Rieders acknowledges his key EPA source may contain a typo inflating the 'normal' EDTA ceiling by a factor of 1,000, potentially destroying the scientific foundation of his opinion while he simultaneously insists the report must be wrong.
Lance A. Ito
I realize you're enjoying yourself, but I'm warning you right now, warning you in no uncertain terms, if I see any more of that commentary, there's going to be severe sanctions, and I underline the word 'Severe.'
Sidebar reprimand capturing the courtroom tension and Clark's aggressively editorializing cross-examination style.
Dr. Fredric Rieders
I do not wait for their permission. I asked them whether they have wishes, not orders. And if their wishes are reasonable, I'll comply with them of course.
Clark's questioning about whether Rieders deferred to defense counsel on contacting Martz paints him as a compliant hired expert; his attempted distinction between 'wishes' and 'permission' rings thin.

Evidence (5)

People's 537
One-page EPA report on EDTA levels, used to challenge Rieders' baseline interpretation
introduced and used to confront Rieders with the mg/ml versus ng/ml discrepancy
People's 538
Document faxed directly from the EPA, which Rieders had not previously seen, containing the same 2 mg/ml figure
introduced to corroborate the underlying report and confirm the contested number was not a transcription error in Rieders' copy
People's 536
Additional EPA paper discussed during questioning about the animal-study basis for the EDTA concentration figure
discussed in connection with whether the 2 mg/ml standard derived from animal rather than human studies
Defense 1257-D
Chart shown to Rieders on direct examination depicting parent and daughter ion data
revisited on cross to probe whether the full daughter spectrum was actually present in the stain evidence
Defense 1259-C
Graph used to examine the 132 daughter ion and retention-time peaks for the sock stain
used by Clark to challenge whether the 132 ion signal rose meaningfully above noise levels

Notable Exchanges (5)

Marcia ClarkDr. Fredric Rieders
Clark walks Rieders through the EPA report typo issue: his key source says '2 mg/ml' which he read as '2 ng/ml.' Clark then produces a confirming EPA document also showing 2 mg/ml, forcing Rieders to simultaneously call it 'absurd' and insist it must be wrong—while having just based his opinion on it.
devastating
Marcia ClarkDr. Fredric Rieders
Clark elicits Rieders' concession that Martz's own unpreserved blood produced EDTA results 'surprisingly' similar to the gate and sock stains, directly undercutting the defense premise that those stains showed anomalously high preservative levels.
devastating
Marcia ClarkDr. Fredric Rieders
Clark presses Rieders on whether he waited for defense counsel approval before contacting Martz. Rieders acknowledges he did not call Martz independently and couches his deference in terms of professional 'wishes' rather than orders—a distinction Clark exploits.
strategic
Marcia ClarkLance A. Ito
At sidebar, Judge Ito sharply reprimands Clark for making editorial comments ('Yes, you see the problem, sir') during questioning, warning of 'severe sanctions.'
heated
Marcia ClarkDr. Fredric RiedersLance A. Ito
Clark uses an analogy about finding women who look like her—height, weight, hair, eyes—to argue that broad identification criteria like retention time are insufficiently discriminating. The judge sustains the objection as 'too oblique,' and Clark quips about whether it was 'the weight thing.'
light

Light Moments (3)

Marcia Clark
After the judge sustained an objection to her analogy about finding women who look like her, Clark quipped: 'Is it because of the weight thing, your Honor?'
Lance A. Ito
Judge Ito's deadpan response to the same analogy: 'It's too oblique for me.'
Dr. Fredric Rieders
When Clark repeated that Rieders had said 'you see the problem,' he corrected her with some heat: 'I said clearly Paragraph, not Problem.'

Credibility Attacks (4)

⚔ Dr. Fredric Rieders
undermining scientific foundation
Clark shows that the EPA figure Rieders interpreted as 'two parts per billion' actually reads '2 mg/ml'—a value 1,000 times higher—raising the possibility his entire conclusion about abnormal EDTA levels rested on a misread typo. A confirming source faxed from the EPA shows the same figure.
⚔ Dr. Fredric Rieders
bias / dependence on retaining party
Clark establishes that Rieders wrote no report until instructed by the defense, did not independently contact Martz despite having his data for months, and deferred to defense counsel's 'wishes' on the timing and scope of his work.
⚔ Dr. Fredric Rieders
lack of hands-on expertise
Clark establishes that Rieders has never operated the electrospray LC tandem mass spectrometer, his lab does not own one, and he is interpreting another expert's instrument output without direct familiarity with that machine's operational characteristics—including how retention time functions in the electrospray context.
⚔ Dr. Fredric Rieders
prior inconsistent conclusion refuted by own expert's data
Clark elicits Rieders' 'surprising' admission that after writing his report he learned Martz's own unpreserved blood showed EDTA characteristics nearly identical to the gate and sock stains—data that directly contradicts the foundation of his opinion that those stains showed levels consistent only with preserved reference blood.

Witness Demeanor

(Brief pause.)
(Discussion held off the record between the Deputy District Attorney and Defense counsel.)
(Discussion held off the record between the Deputy District Attorney and Defense counsel.) (Brief pause.)
(The following proceedings were held at the bench.)
(The following proceedings were held in open court.)

Objections

12 objections (5 sustained, 7 overruled)
Proceeding 7011 • 385 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 JUL 24, 1995 📄 Cross-examination of Dr. Fredr
JUL 24, 1995 KRT DvH TD